Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
Author:
Funder
Bayer HealthCare Pharmaceuticals
Janssen Scientific Affairs, LLC
Publisher
Elsevier BV
Subject
Hematology
Reference48 articles.
1. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Garcia;Chest,2012
2. New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Weitz;Chest,2012
3. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Ageno;Chest,2012
4. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty;Eriksson;N Engl J Med,2008
5. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial;Kakkar;Lancet,2008
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative analysis of andexanet alfa and prothrombin complex concentrate in reversing anticoagulation by rivaroxaban ex vivo;British Journal of Anaesthesia;2024-02
2. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants;Annals of Emergency Medicine;2023-09
3. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03
4. The impact of direct oral anticoagulants on viscoelastic testing – A systematic review;Frontiers in Cardiovascular Medicine;2022-11-07
5. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3